600789 鲁抗医药
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额305,943402,818604,006444,377177,492
投资活动产生之现金流量净额(114,512)(258,870)(369,775)(444,005)(534,405)
筹资活动产生之现金流量净额(145,651)(189,100)(93,923)(5,308)261,324
汇率变动对现金及现金等价物的影响4,72610,8072,7006,457828
现金及现金等价物净增加/(减少)50,506(34,345)143,0071,520(94,762)
期初现金及现金等价物余额495,701530,046387,039385,518480,280
期末现金及现金等价物余额546,207495,701530,046387,039385,518